Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
11.5M
-
Shares change
-
-4.79M
-
Total reported value, excl. options
-
$7.46M
-
Value change
-
-$5.44M
-
Put/Call ratio
-
0.13
-
Number of buys
-
16
-
Number of sells
-
-18
-
Price
-
$0.65
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q3 2022
53 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q3 2022.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.5M shares
of 96M outstanding shares and own 11.96% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (2.54M shares), VANGUARD GROUP INC (1.28M shares), Cormorant Asset Management, LP (1.15M shares), Redmile Group, LLC (696K shares), RENAISSANCE TECHNOLOGIES LLC (687K shares), BAKER BROS. ADVISORS LP (662K shares), Eversept Partners, LP (560K shares), BOXER CAPITAL, LLC (540K shares), Kynam Capital Management, LP (528K shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (464K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.